Generation of Engineered Pluripotent Stem Cell Lines For Clinical Applications

Time: 9:00 am
day: Day Two


  • Showcasing a workflow that implements next generation reagents, methodologies and instruments that enable cGMP manufacturing of engineered hiPSC
  • Detailing advances with tools, reagents and protocols that facilitate the genome editing workflow in hiPSCs
  • Demonstrating how such tools can be readily implemented in the generation of allogeneic hiPSCs for clinical application